Medicine and Dentistry
Ventricular Tachycardia
100%
Implantable Automatic Defibrillator
75%
Atrial Fibrillation
71%
Catheter Ablation
69%
Primary Prevention
61%
Catheter Ablation
46%
Heart Ventricle Arrhythmia
40%
Hazard Ratio
37%
Heart Failure
32%
Sudden Cardiac Death
30%
Antiarrhythmic Agent
30%
Patient Referral
28%
Recurrent Disease
28%
Health Care Cost
26%
Shock (Circulatory)
26%
Ambulatory Care
25%
Drug Therapy
24%
Cost-Effectiveness Analysis
20%
Cardiovascular System
18%
Ischemic Cardiomyopathy
18%
Cardiac Resynchronization Therapy
16%
Electrophysiology
16%
Device Therapy
16%
Retrospective Cohort Study
15%
Arrhythmogenic Right Ventricular Dysplasia
14%
P Wave
14%
Supraventricular Tachycardia
14%
Pulmonary Vein Isolation
14%
Gene Mutation
14%
Cardiac Electrophysiology
14%
Blood Pressure
14%
Pressure Control
14%
Rural Population
14%
Heart Muscle Revascularization
14%
Heart Rehabilitation
14%
Prevalence
14%
DNA Template
14%
Adenosine
14%
Endocardium
13%
Ablation Therapy
12%
Electrography
12%
Heart Left Ventricle Ejection Fraction
11%
Quality Adjusted Life Year
11%
Odds Ratio
10%
Emergency Department
9%
Quality of Life
8%
Tertiary Care
7%
Revascularization
7%
Coronary Artery Disease
6%
Ejection Fraction
6%
Keyphrases
Confidence Interval
34%
Integrated Management
28%
Heart Failure
28%
Sudden Cardiac Death Prevention
28%
Atrial Fibrillation
28%
Implantable Defibrillator
28%
Atrial Fibrillation Clinics
25%
Cost-effectiveness
25%
Quality-adjusted Life Years
20%
Refractory Ventricular Tachycardia
19%
Primary Prevention
18%
Heart Failure Hospitalization
18%
Hazard Ratio
17%
Implantable Cardioverter-defibrillator Shock
15%
Septal Pacing
14%
Ventriculoatrial Conduction
14%
Virtual Platform
14%
Access Roads
14%
Ischemic Scar
14%
TMEM43
14%
Optimal Force
14%
Shock
14%
Inappropriate ICD Therapy
14%
Life-threatening Arrhythmias
14%
Reentrant Ventricular Tachycardia
14%
Bundle Branches
14%
Ventricular Tachycardia Ablation
14%
Cost-utility Analysis
14%
Population-based Cohort
14%
Ambulatory Care
14%
LQT1
14%
P-wave Morphology
14%
Survival Benefit
14%
Cardiac Implantable Electronic Device Complications
14%
Cardiac Resynchronization Therapy
14%
Antiarrhythmic Therapy
14%
Drug Therapy
11%
Localization System
11%
Blood Pressure Treatment
10%
Focal Atrial Tachycardia
10%
Usual Care
10%
Ablation
9%
Lesion Formation
8%
Site Localization
8%
Conduction Recovery
8%
Left Ventricular Ejection Fraction
8%
Nova Scotia
7%
Shock Hazard
7%
Ablation Outcomes
7%
Probabilistic Analysis
7%